Glutamate transporters (EAATs) play an important role in the regulation of extracellular levels of glutamate, a major excitatory neurotransmitter in the central nervous system. Current data suggest that increased extracellular glutamate concentration is involved in the pathophysiology of ischemic brain injury and several major human neurodegenerative disorders, such as Alzheimer's and Huntington's diseases, as well as amyotrophic lateral sclerosis. Thus, normal functioning of EAATs is important for maintaining efficient neurotransmission and preventing neuronal injury. Our long-term research goals are to understand the regulation of EAATs and their role in the mechanisms of anesthesia and neuroprotection. Volatile anesthetics increase the activity of EAATs. Ischemia causes reversed transport of glutamate via EAATs. This proposal aims to 1) determine the effects and mechanisms of volatile anesthetics on the trafficking and activity of EAATs, especially the role of protein kinase C (PKC) in mediating these anesthetic effects; 2) study the anesthetic effects on reversed transport of glutamate via EAATs. Cultured cells will be exposed to volatile anesthetics and cellular distribution of EAATs will be studied by immunocytochemistry with confocal microscopy and Western blotting of the subcellular fractions. The importance of potential PKC-dependent phosphorylation sites in mediating the anesthetic effects on the type 3 glutamate transporter will be determined by site-directed mutagensis. The PKC-isozyme dependence of the anesthetic regulation of this transporter also will be investigated by using isozyme specific inhibitors, down-regulation of isozymes and re-introduction of implicated isozymes. Ischemia-/hypoxia-induced reversed transport of glutamate in different rat brain regions (hippocampus, cerebral cortex and cerebellum) and cultured cell types (glia and neurons) will be evaluated in the presence or absence of volatile anesthetics. These studies will provide a molecular basis for the anesthetic and PKC regulation of glutamate transport and may suggest new targets for anesthesia or neuroprotection.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM065211-05
Application #
7173747
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Cole, Alison E
Project Start
2003-02-01
Project End
2008-01-31
Budget Start
2007-02-01
Budget End
2008-01-31
Support Year
5
Fiscal Year
2007
Total Cost
$245,579
Indirect Cost
Name
University of Virginia
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Wan, Li; Bi, Jiangjiang; Li, Jun et al. (2017) Glutamate transporter type 3 participates in maintaining morphine-induced conditioned place preference. Neuroscience 344:67-73
Tan, Hongying; Bi, Jiangjiang; Wang, Yunzhen et al. (2015) Transfusion of Old RBCs Induces Neuroinflammation and Cognitive Impairment. Crit Care Med 43:e276-86
Wang, Zhi; Li, Liaoliao; Zhao, Huijuan et al. (2015) Chronic high fat diet induces cardiac hypertrophy and fibrosis in mice. Metabolism 64:917-25
Wang, Zhi; Feng, Chenzhuo; Zhao, Huijuan et al. (2015) Autoregulation of inducible nitric oxide synthase expression by RNA interference provides neuroprotection in neonatal rats. Theranostics 5:504-14
Deng, Jiao; Xiong, Lize; Zuo, Zhiyi (2015) Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice. J Neurosci Res 93:615-22
Zhang, Junfeng; Tan, Hongying; Jiang, Wei et al. (2015) The choice of general anesthetics may not affect neuroinflammation and impairment of learning and memory after surgery in elderly rats. J Neuroimmune Pharmacol 10:179-89
Ren, Xiaoyan; Wang, Zhi; Ma, Hong et al. (2014) Sevoflurane postconditioning provides neuroprotection against brain hypoxia-ischemia in neonatal rats. Neurol Sci 35:1401-4
Feng, Chenzhuo; Zhang, Ying; Yin, Jinbo et al. (2014) Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma. Neuro Oncol 16:1078-85
Zhang, Junfeng; Tan, Hongying; Jiang, Wei et al. (2014) Amantadine alleviates postoperative cognitive dysfunction possibly by increasing glial cell line-derived neurotrophic factor in rats. Anesthesiology 121:773-85
Yin, Jinbo; Li, Hong; Feng, Chenzhuo et al. (2014) Inhibition of brain ischemia-caused notch activation in microglia may contribute to isoflurane postconditioning-induced neuroprotection in male rats. CNS Neurol Disord Drug Targets 13:718-32

Showing the most recent 10 out of 91 publications